Deintensification in older patients with type 2 diabetes: A systematic review of approaches, rates and outcomes

Abstract

To assess deintensification approaches and rates and evaluate the harm and benefits of deintensification with antidiabetic medication and other therapies among older people (≥ 65\u2009years) with type 2 diabetes with or without cardiometabolic conditions.